Move over, Tesla’s CEO Elon Musk. Clinton’s tweet moves markets in a big way.Tesla: +0.5%Biotech index - 3.36%.(Paraphrased) - We are releasing bigger batteries.Clinton:https://twitter.com/HillaryClinton/status/768508732623970304!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");Clinton is now setting the cross-hairs against Mylan (MYL) regarding EpiPen pricing. Note: I covered this two days ago in the marketplace subscription series yesterday. Twice. Article titles: Mylan: Making Mad Stacks Of Cash Selling EpiPens To Nerds With Peanut AllergiesWhy Valeant And Nintendo Matters To Us There is no doubt the biotech (IBB) sector is on the action list tomorrow.Tomorrow’s moves: 1.Valeant, set to fly higher as it crossed $30 - $32, may get muddled in the Mylan/price hike controversy2.Pfizer, whose stock is not hurting with the biotech pull-back, may run out of luck.3.Fed rate hike looms. Yellen speaks on Friday. Likelihood of September rate hike is remote. December is more likely. Either way, a higher rate will hurt biotech.4.Cry.5.Cry more.6.Do not panic.7.Join this group, because value stocks seek stocks trading at a discount. That “margin of safety” should shield investors from major losses.8.Post your move, below. It is not limited to biotech stocks.